van Houdt et al., 2018 - Google Patents
Performance of a fast and high‐resolution multi‐echo spin‐echo sequence for prostate T2 mapping across multiple systemsvan Houdt et al., 2018
View PDF- Document ID
- 9335337724189176860
- Author
- van Houdt P
- Agarwal H
- van Buuren L
- Heijmink S
- Haack S
- van der Poel H
- Ghobadi G
- Pos F
- Peeters J
- Choyke P
- van der Heide U
- Publication year
- Publication venue
- Magnetic resonance in medicine
External Links
Snippet
Purpose To evaluate the performance of a multi‐echo spin‐echo sequence with k‐t undersampling scheme (k‐t T2) in prostate cancer. Methods Phantom experiments were performed at five systems to estimate the bias, short‐term repeatability, and reproducibility …
- 210000002307 Prostate 0 title abstract description 24
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/565—Correction of image distortions, e.g. due to magnetic field inhomogeneities
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/58—Calibration of imaging systems, e.g. using test probes, Phantoms; Calibration objects or fiducial markers such as active or passive RF coils surrounding an MR active material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/4806—Functional imaging of brain activation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R31/00—Arrangements for testing electric properties; Arrangements for locating electric faults; Arrangements for electrical testing characterised by what is being tested not provided for elsewhere
- G01R31/28—Testing of electronic circuits, e.g. by signal tracer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves involving electronic or nuclear magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R35/00—Testing or calibrating of apparatus covered by the preceding groups
Similar Documents
Publication | Publication Date | Title |
---|---|---|
van Houdt et al. | Performance of a fast and high‐resolution multi‐echo spin‐echo sequence for prostate T2 mapping across multiple systems | |
Dimov et al. | Bone quantitative susceptibility mapping using a chemical species–specific signal model with ultrashort and conventional echo data | |
Togao et al. | Amide proton transfer imaging of brain tumors using a self‐corrected 3D fast spin‐echo dixon method: comparison with separate B0 correction | |
Zhong et al. | Liver fat quantification using a multi‐step adaptive fitting approach with multi‐echo GRE imaging | |
Zhang et al. | CEST‐Dixon for human breast lesion characterization at 3 T: A preliminary study | |
Deh et al. | Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors | |
By et al. | Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T | |
Scheidegger et al. | Amide proton transfer imaging with improved robustness to magnetic field inhomogeneity and magnetization transfer asymmetry using saturation with frequency alternating RF irradiation | |
Yarnykh | Fast macromolecular proton fraction mapping from a single off‐resonance magnetization transfer measurement | |
Jacobs et al. | Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study | |
Togao et al. | Scan–rescan reproducibility of parallel transmission based amide proton transfer imaging of brain tumors | |
Meyers et al. | Multicenter measurements of myelin water fraction and geometric mean T2: intra‐and intersite reproducibility | |
Keene et al. | T2 relaxation‐time mapping in healthy and diseased skeletal muscle using extended phase graph algorithms | |
EP2205986B1 (en) | Frequency referencing for chemical exchange saturation transfer (cest) mri | |
Sabati et al. | Multivendor implementation and comparison of volumetric whole‐brain echo‐planar MR spectroscopic imaging | |
Baudrexel et al. | T1 mapping with the variable flip angle technique: a simple correction for insufficient spoiling of transverse magnetization | |
QSM Consensus Organization Committee et al. | Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: a consensus of the ISMRM electro‐magnetic tissue properties study group | |
Yao et al. | Fat-corrected T2 measurement as a marker of active muscle disease in inflammatory myopathy | |
Schakel et al. | Diffusion‐weighted MRI with minimal distortion in head‐and‐neck radiotherapy using a turbo spin echo acquisition method | |
Rahbar et al. | Improved B1 homogeneity of 3 tesla breast MRI using dual‐source parallel radiofrequency excitation | |
Schwartz et al. | Multisite reliability and repeatability of an advanced brain MRI protocol | |
Keene et al. | The feasibility of quantitative MRI of extra‐ocular muscles in myasthenia gravis and Graves' orbitopathy | |
Heo et al. | Prospective acceleration of parallel RF transmission‐based 3D chemical exchange saturation transfer imaging with compressed sensing | |
Hutton et al. | Validation of a standardized MRI method for liver fat and T2* quantification | |
Berrington et al. | A comparison of 2‐hydroxyglutarate detection at 3 and 7 T with long‐TE semi‐LASER |